Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Combined accelerated tissue-plasminogen activator and platelet glycoprotein iib/iiia integrin receptor blockade with integrin in acute myocardial infarction - results of a randomized, placebo-controlled, dose-ranging trial

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Ohman, E. M.
  • Kleiman, N. S.
  • Gacioch, G.
  • Worley, S. J.
  • Navetta, F. I.
  • Talley, J. D.
  • Anderson, H. V.
  • Ellis, S. G.
  • Cohen, M. D.
  • Spriggs, D.
  • Miller, M.
  • Kereiakes, D.
  • Yakubov, S.
  • Kitt, M. M.
  • Sigmon, K. N.
  • Califf, R. M.
  • Krucoff, M. W.
  • Topol, Eric

publication date

  • February 1997

journal

  • Circulation  Journal

subject areas

  • Adult
  • Aged
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Therapy, Combination
  • Electrocardiography
  • Female
  • Fibrinolytic Agents
  • Heparin
  • Humans
  • Infusions, Intravenous
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Monitoring, Physiologic
  • Myocardial Infarction
  • Peptides
  • Placebos
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Tissue Plasminogen Activator
scroll to property group menus

Research

keywords

  • myocardial infarction
  • platelet aggregation inhibitors
  • reperfusion
  • thrombolysis
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0009-7322

PubMed ID

  • 9054741
scroll to property group menus

Additional Document Info

start page

  • 846

end page

  • 854

volume

  • 95

issue

  • 4

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support